Global Regenerative Medicine Market to Reach $30.8 Billion by 2030
The global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR
The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.Select Competitors (Total 52 Featured) -
- AlloSource
- Anika Therapeutics, Inc.
- Bioventus LLC
- DePuy Synthes Spine, Inc.
- Exactech, Inc.
- Integra LifeSciences Holdings Corp.
- LifeNet Health, Inc.
- Medtronic, PLC
- NovaBone Products LLC
- NuVasive, Inc.
- Orthofix International N.V.
- Osiris Therapeutics, Inc.
- Smith & Nephew plc
- Stryker Corporation
- Wright Medical Technology, Inc.
- Zimmer Biomet Holdings, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AlloSource
- Anika Therapeutics, Inc.
- Bioventus LLC
- DePuy Synthes Spine, Inc.
- Exactech, Inc.
- Integra LifeSciences Holdings Corp.
- LifeNet Health, Inc.
- Medtronic, PLC
- NovaBone Products LLC
- NuVasive, Inc.
- Orthofix International N.V.
- Osiris Therapeutics, Inc.
- Smith & Nephew plc
- Stryker Corporation
- Wright Medical Technology, Inc.
- Zimmer Biomet Holdings, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 198 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 9.6 Billion |
Forecasted Market Value ( USD | $ 30.8 Billion |
Compound Annual Growth Rate | 15.7% |
Regions Covered | Global |